Primary mucosal melanomas: A comprehensive review

International Journal of Clinical and Experimental Pathology

Volumn 5, Issue 8, 2012, Pages 739-753

  Mihajlovic, Marija ^a   Vlajkovic, Slobodan ^a   Jovanovic, Predrag ^a   Stefanovic, Vladisav ^a  

^a Department of Clinical Research ^*  (Serbia)

Author keywords

Gastrointestinal; Mucosal melanoma; Respiratory; Urogenital

Indexed keywords

COMPARATIVE STUDY; FEMALE; FEMALE GENITAL TRACT TUMOR; HEAD AND NECK TUMOR; HUMAN; MALE; MELANOCYTE; MELANOMA; MOUTH TUMOR; MUCOSA; MULTIMODALITY CANCER THERAPY; PARANASAL SINUS TUMOR; PATHOLOGY; RECTUM TUMOR; REVIEW; SKIN TUMOR; SURVIVAL RATE;

COMBINED MODALITY THERAPY; FEMALE; GENITAL NEOPLASMS, FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MELANOCYTES; MELANOMA; MOUTH NEOPLASMS; MUCOUS MEMBRANE; PARANASAL SINUS NEOPLASMS; RECTAL NEOPLASMS; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 84870439771     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Review

References (121)

1. Dupin E, Le Douarin NM. Development of melanocyte precursors from the vertebrate neural crest. Oncogene 2003; 22: 3016-23.
2. Goldgeier MH, Klein LE, Klein-Angerer S, Moellmann G, Nordlund JJ. The distribution of melanocytes in the leptomeninges of the human brain. J Invest Dermatol 1984; 82: 235-238.
3. Barrett AW, Raja AM. The immunohistochemical identification of human oral mucosal melanocytes. Arch Oral Biol 1997; 42: 77-81.
4. De La Pava S, Nigogosyan G, Pickren JW, Cabrera A. Melanosis of the esophagus. Cancer 1963: 16: 48-50.
5. Werdin C, Limas C, Knodell RG. Primary malignant melanoma of the rectum. Evidence for origination from rectal mucosal melanocytes. Cancer 1988; 61: 1364-1370.
6. Clemmensen OJ, Fenger C. Melanocytes in the anal canal epithelium. Histopathology 1991; 18: 237-41.
7. Zak FG, Lawson W. The presence of melanocytes in the nasal cavity. Ann Otol Rhinol Laryngol 1974; 83: 515-9.
8. Uehara T, Matsubara O, Kasuga T. Melanocytes in the nasal cavity and paranasal sinus. Incidence and distribution in Japan. Acta Pathol Jpn 1987; 37: 1105-14.
9. Goldman JL, Lawson W, Zak FG, Roffman JD. The presence of melanocytes in the human larynx. Laryngoscope 1972; 82: 824-835.
10. Nigogosyan G, De La Pava S, Pickren JW. Melanoblasts in vaginal mucosa. Origin for primary malignant melanoma. Cancer 1964; 17: 912-3.
11. Uehara T, Takayama S, Takemura T, Kasuga T. Foci of stromal melanocytes (so-called blue naevus) of the uterine cervix in Japanese women. Virchows Arch A Pathol Anat Histopathol 1991; 418: 327-31.
12. Mackintosh JA. The antimicrobial properties of melanocytes, melanosomes and melanin and the evolution of black skin. J Theor Biol 2001; 211: 101-13.
13. Plonka PM, Passeron T, Brenner M, Tobin DJ, Shibahara S, Thomas A, Slominski A, Kadekaro AL, Hershkovitz D, Peters E, Nordlund JJ, Abdel-Malek Z, Takeda K, Paus R, Ortonne JP, Hearing VJ, Schallreuter KU. What are melanocytes really doing all day long...? Exp Dermatol 2009; 18: 799-819.
14. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29.
15. McLaughlin CC, Wu XC, Jemal A, Martin HJ, Roche LM, Chen VW. Incidence of noncutaneous melanomas in the U.S. Cancer 2005; 103: 1000-7.
16. Simard EP, Ward EM, Siegel R, Jemal A. Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin 2012 Jan 4. doi: 10.3322/caac.20141. [Epub ahead of print].
17. Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma. Cancer 1998; 83: 1664-1678.
18. Hu DN, Yu G, McCormick SA, Finger PT. Population-based incidence of conjunctival melanoma in various races and ethnic groups and comparison with other melanomas. Am J Ophthalmol 2008; 145: 418-423.
19. Dahlgren L, Schedvins K, Kanter-Lewensohn L, Dalianis T, Ragnarsson-Olding BK. Human papilloma virus (HPV) is rarely detected in malignant melanomas of sun sheltered mucosal membranes. Acta Oncol 2005; 44: 694-9.
20. Lundberg R, Brytting M, Dahlgren L, Kanter-Lewensohn L, Schloss L, Dalianis T, Ragnarsson-Olding B. Human herpes virus DNA is rarely detected in non-UV light-associated primary malignant melanomas of mucous membranes. Anticancer Res 2006; 26: 3627-31.
21. Giraud G, Ramqvist T, Ragnarsson-Olding B, Dalianis T. DNA from BK virus and JC virus and from KI, WU, and MC polyomaviruses as well as from simian virus 40 is not detected in non-UV-light-associated primary malignant melanomas of mucous membranes. J Clin Microbiol 2008; 46: 3595-8.
22. Holmstrom M, Lund VJ. Malignant melanomas of the nasal cavity after occupational exposure to formaldehyde. Br J Ind Med 1991; 48: 9-11.
23. Thompson LD, Wieneke JA, Miettinen M. Sinonasal tract and nasopharyngeal melanomas: a clinicopathologic study of 115 cases with a proposed staging system. Am J Surg Pathol 2003; 27: 594-611.
24. Axell T, Hedin CA. Epidemiologic study of excessive oral melanin pigmentation with special reference to the influence of tobacco habits. Scand J Dental Res 1982; 90: 434-42.
25. Aoki H, Yamada Y, Hara A, Kunisada T. Two distinct types of mouse melanocyte: differential signaling requirement for the maintenance of non-cutaneous and dermal versus epidermal melanocytes. Development 2009; 136: 2511-21.
26. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA. Mutations of the BRAF gene in human cancer. Nature 2002; 417: 949-54.
27. Poynter JN, Elder JT, Fullen DR, Nair RP, Soengas MS, Johnson TM, Redman B, Thomas NE, Gruber SB. BRAF and NRAS mutations in melanoma and melanocytic nevi. Melanoma Res 2006; 16: 267-73.
28. Maldonado JL, Fridlyand J, Patel H, Jain AN, Busam K, Kageshita T, Ono T, Albertson DG, Pinkel D, Bastian BC. Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst 2003; 95: 1878-90.
29. Curtin JA, Busam K, Pinkel D, Bastian BC. Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol 2006; 24: 4340-6.
30. Beadling C, Jacobson-Dunlop E, Hodi FS, Le C, Warrick A, Patterson J, Town A, Harlow A, Cruz F 3rd, Azar S, Rubin BP, Muller S, West R, Heinrich MC, Corless CL. KIT gene mutations and copy number in melanoma subtypes. Clin Cancer Res 2008; 14: 6821-8.
31. Van Raamsdonk CD, Bezrookove V, Green G, Bauer J, Gaugler L, O'Brien JM, Simpson EM, Barsh GS, Bastian BC. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 2009; 457: 599-602.
32. Van Raamsdonk CD, Griewank KG, Crosby MB, Garrido MC, Vemula S, Wiesner T, Obenauf AC, Wackernagel W, Green G, Bouvier N, Sozen MM, Baimukanova G, Roy R, Heguy A, Dolgalev I, Khanin R, Busam K, Speicher MR, O'Brien J, Bastian BC. Mutations in GNA11 in uveal melanoma. N Engl J Med 2010; 363: 2191-9.
33. Sanchez AA, Wu TT, Prieto VG, Rashid A, Hamilton SR, Wang H. Comparison of primary and metastatic malignant melanoma of the esophagus: clinicopathologic review of 10 cases. Arch Pathol Lab Med 2008; 132: 1623-9.
34. Allen AC, Spitz S. Malignant melanoma; a clinicopathological analysis of the criteria for diagnosis and prognosis. Cancer 1953; 6: 1-45.
35. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010; 17: 1471-4.
36. Leiter U, Meier F, Schittek B, Garbe C. The natural course of cutaneous melanoma. J Surg Oncol 2004; 86: 172-8.
37. Collaborative Ocular Melanoma Study Group. Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS report no. 15. Arch Ophthalmol 2001; 119: 670-6.
38. DeMatos P, Tyler DS, Seigler HF. Malignant melanoma of the mucous membranes: a review of 119 cases. Ann Surg Oncol 1998; 5: 733-42.
39. Hicks MJ, Flaitz CM. Oral mucosal melanoma: epidemiology and pathobiology. Oral Oncol 2000; 36: 152-69.
40. Manolidis S, Donald PJ. Malignant mucosal melanoma of the head and neck: review of the literature and report of 14 patients. Cancer 1997; 80: 1373-86.
41. Moreno MA, Roberts DB, Kupferman ME, De-Monte F, El-Naggar AK, Williams M, Rosenthal DS, Hanna EY. Mucosal melanoma of the nose and paranasal sinuses, a contemporary experience from the M. D. Anderson Cancer Center. Cancer 2010; 116: 2215-2223.
42. Owens JM, Roberts DB, Myers JN. The role of postoperative adjuvant radiation therapy in the treatment of mucosal melanomas of the head and neck region. Arch Otolaryngol Head Neck Surg 2003; 129: 864-8.
43. Krengli M, Jereczek-Fossa BA, Kaanders JH, Masini L, Beldi D, Orecchia R. What is the role of radiotherapy in the treatment of mucosal melanoma of the head and neck? Crit Rev Oncol Hematol 2008; 65: 121-128.
44. Benlyazid A, Thariat J, Temam S, Malard O, Florescu C, Choussy O, Makeieff M, Poissonnet G, Penel N, Righini C, Toussaint B, Lacau St Guily J, Vergez S, Filleron T. Postoperative radiotherapy in head and neck mucosal melanoma: a GETTEC study. Arch Otolaryngol Head Neck Surg 2010; 136: 1219-25.
45. Clifton N, Harrison L, Bradley PJ, Jones NS. Malignant melanoma of nasal cavity and paranasal sinuses: report of 24 patients and literature review. J Laryngol Otol 2011; 125: 479-85.
46. Roth TN, Gengler C, Huber GF, Holzmann D. Outcome of sinonasal melanoma: clinical experience and review of the literature. Head Neck 2010; 32: 1385-92.
47. Terada T, Saeki N, Toh K, Uwa N, Sagawa K, Mouri T, Sakagami M. Primary malignant melanoma of the larynx: a case report and literature review. Auris Nasus Larynx 2007; 34: 105-10.
48. Wenig BM. Laryngeal mucosal malignant melanoma. A clinicopathologic, immunohistochemical, and ultrastructural study of four patients and a review of the literature. Cancer 1995; 75: 1568-77.
49. Amin HH, Petruzzelli GJ, Husain AN, Nickoloff BJ. Primary malignant melanoma of the larynx. Arch Pathol Lab Med 2001; 125: 271-3.
50. Reddy VS, Mykytenko J, Ciltman LI, Mansour KA. Primary malignant melanoma of the lung: review of literature and report of a case. Am Surg 2007; 73: 287-9.
51. Pan XD, Zhang B, Guo LC, Gu DM, Mao YQ, Li J, Xie Y, Wang L. Primary malignant melanoma of the lung in the elderly: case report and literature review. Chin Med J (Engl) 2010; 123: 1815-7.
52. Taboada CF, McMurray JD, Jordan RA, Seybold WD. Primary melanoma of the lung. Chest 1972; 62: 629-31.
53. Ost D, Joseph C, Sogoloff H, Menezes G. Primary pulmonary melanoma: case report and literature review. Mayo Clin Proc 1999; 74: 62-6.
54. Zuckermann B, Papiashvilli M, Bar I. Primary pulmonary malignant melanoma of right upper lobe of lung. Isr Med Assoc J 2011; 13: 440-1.
55. Cheung MC, Perez EA, Molina MA, Jin X, Gutierrez JC, Franceschi D, Livingstone AS, Koniaris LG. Defining the role of surgery for primary gastrointestinal tract melanoma. J Gastrointest Surg 2008; 12: 731-8.
56. Reintgen DS, Thompson W, Garbutt J, Seigler HF. Radiologic, endoscopic, and surgical considerations of melanoma metastatic to the gastrointestinal tract. Surgery 1984; 95: 635-9.
57. Capizzi PJ, Donohue JH. Metastatic melanoma of the gastrointestinal tract: a review of the literature. Compr Ther 1994; 20: 20-3.
58. Takagi M, Ishikawa G, Mori W. Primary malignant melanoma of the oral cavity in japan. With Special Reference to Mucosal Melanosis. Cancer 1974; 34: 358-370.
59. Tanaka N, Amagasa T, Iwaki H, Shioda S, Takeda M, Ohashi K, Reck SF. Oral malignant melanoma in Japan. Oral Surg Oral Med Oral Pathol 1994; 78: 81-90.
60. Yanagi K, Haneji N, Ishimaru N, Hamano H, Hayashi Y. Immunopathological analysis of mucosal melanocyte distribution in the human lower lip of the elderly. Pathobiology 1996; 64: 156-60.
61. McLean N, Tighiouart M, Muller S. Primary mucosal melanoma of the head and neck. Comparison of clinical presentation and histopathologic features of oral and sinonasal melanoma. Oral Oncol 2008; 44: 1039-46.
62. Aguas SC, Quarracino MC, Lence AN, Lanfranchi-Tizeira HE. Primary melanoma of the oral cavity: ten cases and review of 177 cases from literature. Med Oral Patol Oral Cir Bucal 2009; 14: E265-71.
63. Patrick RJ, Fenske NA, Messina JL. Primary mucosal melanoma. J Am Acad Dermatol 2007; 56: 828-34.
64. Devi P, Bhovi T, Jayaram RR, Walia C, Singh S. Malignant melanoma of the oral cavity showing satellitism. J Oral Sci 2011; 53: 239-44.
65. Notani K, Shindoh M, Yamazaki Y, Nakamura H, Watanabe M, Kogoh T, Ferguson MM, Fukuda H. Amelanotic malignant melanomas of the oral mucosa. Br J Oral Maxillofac Surg 2002; 40: 195-200.
66. Patel SG, Prasad ML, Escrig M, Singh B, Shaha AR, Kraus DH, Boyle JO, Huvos AG, Busam K, Shah JP. Primary mucosal malignant melanoma of the head and neck. Head Neck 2002; 24: 247-57.
67. Bisceglia M, Perri F, Tucci A, Tardio M, Panniello G, Vita G, Pasquinelli G. Primary malignant melanoma of the esophagus: a clinicopathologic study of a case with comprehensive literature review. Adv Anat Pathol 2011; 18: 235-52.
68. Ohashi K, Kato Y, Kanno J, Kasuga T. Melanocytes and melanosis of the oesophagus in Japanese subjects--analysis of factors effecting their increase. Virchows Arch A Pathol Anat Histopathol 1990; 417: 137-43.
69. Sabanathan S, Eng J, Pradhan GN. Primary malignant melanoma of the esophagus. Am J Gastroenterol 1989; 84: 1475-81.
70. Iwanuma Y, Tomita N, Amano T, Isayama F, Tsurumaru M, Hayashi T, Kajiyama Y. Current status of primary malignant melanoma of the esophagus: clinical features, pathology, management and prognosis. J Gastroenterol 2012; 47: 21-8.
71. Stringa O, Valdez R, Beguerie JR, Abbruzzese M, Lioni M, Nadales A, Iudica F, Venditti J, San Roman A. Primary amelanotic melanoma of the esophagus. Int J Dermatol 2006; 45: 1207-10.
72. Adili F, Mönig SP. Surgical therapy of primary malignant melanoma of the esophagus. Ann Thorac Surg 1997; 63: 1461-3.
73. Volpin E, Sauvanet A, Couvelard A, Belghiti J. Primary malignant melanoma of the esophagus: a case report and review of the literature. Dis Esophagus 2002; 15: 244-9.
74. Jelincic Z, Jakic-Razumovic J, Petrovic I, Cavcic AM, Unusic J, Trotic R. Primary malignant melanoma of the stomach. Tumori 2005; 91: 201-3.
75. Ravi A. Primary gastric melanoma: a rare cause of upper gastrointestinal bleeding. Gastroenterol Hepatol (N Y) 2008; 4: 795-7.
76. Khaliq A, Siddappa PK, Thandassery RB, Kochhar R, Bhattacharya A, Vaiphei K, Singh K. (2011) Melanoma of Stomach. J Gastrointest Cancer 2011 Nov 29. [Epub ahead of print].
77. Amar A, Jougon J, Edouard A, Laban P, Marry JP, Hillion G. [Primary malignant melanoma of the small intestine]. Gastroenterol Clin Biol 1992; 16: 365-7. [Article in French].
78. Elsayed AM, Albahra M, Nzeako UC, Sobin LH. Malignant melanomas in the small intestine: a study of 103 patients. Am J Gastroenterol 1996; 91: 1001-6.
79. Krüger S, Noack F, Blöchle C, Feller AC. Primary malignant melanoma of the small bowel: a case report and review of the literature. Tumori 2005; 91: 73-6.
80. Coté TR, Sobin LH. Primary melanomas of the esophagus and anorectum: epidemiologic comparison with melanoma of the skin. Melanoma Res 2009; 19: 58-60.
81. Iddings DM, Fleisig AJ, Chen SL, Faries MB, Morton DL. Practice patterns and outcomes for anorectal melanoma in the USA, reviewing three decades of treatment: is more extensive surgical resection beneficial in all patients? Ann Surg Oncol 2010; 17: 40-4.
82. Zhang S, Gao F, Wan D. Effect of misdiagnosis on the prognosis of anorectal malignant melanoma. J Cancer Res Clin Oncol 2010; 136: 1401-5.
83. Chute DJ, Cousar JB, Mills SE. Anorectal malignant melanoma: morphologic and immunohistochemical features. Am J Clin Pathol 2006; 126: 93-100.
84. Hillenbrand A, Barth TF, Henne-Bruns D, Formentini A. Anorectal amelanotic melanoma. Colorectal Dis 2008; 10: 612-5.
85. Zhou HT, Zhou ZX, Zhang HZ, Bi JJ, Zhao P. Wide local excision could be considered as the initial treatment of primary anorectal malignant melanoma. Chin Med J (Engl) 2010; 123: 585-8.
86. Weyandt GH, Eggert AO, Houf M, Raulf F, Bröcker EB, Becker JC. Anorectal melanoma: surgical management guidelines according to tumour thickness. Br J Cancer 2003; 89: 2019-22.
87. Yap LB, Neary P. A comparison of wide local excision with abdominoperineal resection in anorectal melanoma. Melanoma Res 2004; 14: 147-50.
88. Droesch JT, Flum DR, Mann GN. Wide local excision or abdominoperineal resection as the initial treatment for anorectal melanoma? Am J Surg 2005; 189: 446-9.
89. Ross M, Pezzi C, Pezzi T, Meurer D, Hickey R, Balch C. Patterns of failure in anorectal melanoma. A guide to surgical therapy. Arch Surg 1990; 125: 313-6.
90. Che X, Zhao DB, Wu YK, Wang CF, Cai JQ, Shao YF, Zhao P. Anorectal malignant melanomas: retrospective experience with surgical management. World J Gastroenterol 2011; 17: 534-9.
91. Kelly P, Zagars GK, Cormier JN, Ross MI, Guadagnolo BA. Sphincter-sparing local excision and hypofractionated radiation therapy for anorectal melanoma: A 20-Year Experience. Cancer 2011; 117: 4747-4755.
92. Khalid U, Saleem T, Imam AM, Khan MR. Pathogenesis, diagnosis and management of primary melanoma of the colon. World J Surg Oncol 2011; 9: 14.
93. Kenney B, Dotto J, Homer R, Shafi N, Davydova L. Primary malignant melanoma of the transverse colon: report of a case and review of the literature. Int J Surg Pathol 2007; 15: 401-7.
94. Smith NE, Taube JM, Warczynski TM, Collier KD, Pawlik TM. Primary biliary tract melanoma: Report of a case and review of the literature. Int J Surg Case Rep 2012; 3: 441-4.
95. Gligorijevic J, Zivkovic V, Djordjevic B, Dimov I. Primary gallbladder melanoma in dysplastic nevus syndrome: report of case and literature review. Turk J Gastroenterol 2011; 22: 626-30.
96. Velez AF, Penetrante RB, Spellman JE Jr, Orozco A, Karakousis CP. Malignant melanoma of the gallbladder: report of a case and review of the literature. Am Surg 1995; 61: 1095-8.
97. Sugiyama VE, Chan JK, Shin JY, Berek JS, Osann K, Kapp DS. Vulvar melanoma: a multivariable analysis of 644 patients. Obstet Gynecol 2007; 110: 296-301.
98. Weinstock MA. Malignant melanoma of the vulva and vagina in the United States: patterns of incidence and population-based estimates of survival. Am J Obstet Gynecol 1994; 171: 1225-30.
99. Ragnarsson-Olding BK, Kanter-Lewensohn LR, Lagerlöf B, Nilsson BR, Ringborg UK. Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females: clinical observations and histopathologic features. Cancer 1999; 86: 1273-84.
100. Verschraegen CF, Benjapibal M, Supakarapongkul W, Levy LB, Ross M, Atkinson EN, Bodurka-Bevers D, Kavanagh JJ, Kudelka AP, Legha SS. Vulvar melanoma at the M. D. Anderson Cancer Center: 25 years later. Int J Gynecol Cancer 2001; 11: 359-64.
101. Ragnarsson-Olding BK, Nilsson BR, Kanter-Lewensohn LR, Lagerlöf B, Ringborg UK. Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females: predictors of survival. Cancer 1999; 86: 1285-93.
102. Piura B. Management of primary melanoma of the female urogenital tract. Lancet Oncol 2008; 9: 973-81.
103. Gungor T, Altinkaya SO, Ozat M, Bayramoglu H, Mollamahmutoglu L. Primary malignant melanoma of the female genital tract. Taiwan J Obstet Gynecol 2009; 48: 169-75.
104. Reid GC, Schmidt RW, Roberts JA, Hopkins MP, Barrett RJ, Morley GW. Primary melanoma of the vagina: a clinicopathologic analysis. Obstet Gynecol 1989; 74: 190-9.
105. Frumovitz M, Etchepareborda M, Sun CC, Soliman PT, Eifel PJ, Levenback CF, Ramirez PT. Primary malignant melanoma of the vagina. Obstet Gynecol 2010; 116: 1358-65.
106. Miner TJ, Delgado R, Zeisler J, Busam K, Alektiar K, Barakat R, Poynor E. Primary vaginal melanoma: a critical analysis of therapy. Ann Surg Oncol 2004; 11: 34-9.
107. An J, Wu L, Li B, Lu H, Li N, Ma S. Primary Malignant Amelanotic Melanoma in the Female Genital Tract: A Report of Six Cases and a Review of the Literature. Chin J Clin Oncol 2008; 5: 383-386.
108. Buchanan DJ, Schlaerth J, Kurosaki T. Primary vaginal melanoma: thirteen-year disease-free survival after wide local excision and review of recent literature. Am J Obstet Gynecol 1998; 178: 1177-84.
109. Cobellis L, Calabrese E, Stefanon B, Raspagliesi F. Malignant melanoma of the vagina. A report of 15 cases. Eur J Gynaecol Oncol 2000; 21: 295-7.
110. Ragnarsson-Olding B, Johansson H, Rutqvist LE, Ringborg U. Malignant melanoma of the vulva and vagina. Trends in incidence, age distribution, and long-term survival among 245 consecutive cases in Sweden 1960-1984. Cancer 1993; 71: 1893-7.
111. Petru E, Nagele F, Czerwenka K, Graf AH, Lax S, Bauer M, Pehamberger H, Vavra N. Primary malignant melanoma of the vagina: long-term remission following radiation therapy. Gynecol Oncol 1998; 70: 23-6.
112. Pusceddu S, Bajetta E, Carcangiu ML, Formisano B, Ducceschi M, Buzzoni R. A literature overview of primary cervical malignant melanoma: an exceedingly rare cancer. Crit Rev Oncol Hematol 2012; 81: 185-95.
113. Cantuaria G, Angioli R, Nahmias J, Estape R, Penalver M. Primary malignant melanoma of the uterine cervix: case report and review of the literature. Gynecol Oncol 1999; 75: 170-4.
114. DiMarco DS, DiMarco CS, Zincke H, Webb MJ, Keeney GL, Bass S, Lightner DJ. Outcome of surgical treatment for primary malignant melanoma of the female urethra. J Urol 2004; 171: 765-7.
115. Gupta R, Bhatti SS, Dinda AK, Singh MK. Primary melanoma of the urethra: a rare neoplasm of the urinary tract. Int Urol Nephrol 2007; 39: 833-6.
116. Nakamoto T, Inoue Y, Ueki T, Niimi N, Iwasaki Y. Primary amelanotic malignant melanoma of the female urethra. Int J Urol 2007; 14: 153-5.
117. Pacella M, Gallo F, Gastaldi C, Ambruosi C, Carmignani G. Primary malignant melanoma of the bladder. Int J Urol 2006; 13: 635-7.
118. Khalbuss WE, Hossain M, Elhosseiny A. Primary malignant melanoma of the urinary bladder diagnosed by urine cytology: a case report. Acta Cytol 2001; 45: 631-5.
119. Efesoy O, Cayan S. Bladder metastasis of malignant melanoma: a case report and review of literature. Med Oncol 2011; 28 (Suppl 1): S667-9.
120. Hodi FS, Friedlander P, Corless CL, Heinrich MC, Mac Rae S, Kruse A, Jagannathan J, Van den Abbeele AD, Velazquez EF, Demetri GD, Fisher DE. Major response to imatinib mesylate in KIT-mutated melanoma. J Clin Oncol 2008; 26: 2046-51.
121. Minor DR, Kashani-Sabet M, Garrido M, O'Day SJ, Hamid O, Bastian BC. Sunitinib therapy for melanoma patients with KIT mutations. Clin Cancer Res 2012; 18: 1457-63.